Spain · AEMPS CIMA
ABACAVIR/LAMIVUDINA KERN PHARMA 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84182
- Form
- COMPRIMIDO RECUBIERTO CON PELÍCULA
- Composition / generic term
- abacavir + lamivudina
- Source strength
- 600 mg/ 300 mg
- Authorisation holder
- Kern Pharma S.L.
- Marketed in source snapshot
- No
Source-listed ingredients
- ABACAVIR — 600 mg
- LAMIVUDINA — 300 mg
These values do not establish equivalence or a dose recommendation.
Packages
- ABACAVIR/LAMIVUDINA KERN PHARMA 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (Blister PVC/Aclar/Al)
- ABACAVIR/LAMIVUDINA KERN PHARMA 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (Blister PVC/PVDC/Al)
Source and coverage
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →